641 related articles for article (PubMed ID: 15317910)
1. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.
Simmons DL; Botting RM; Hla T
Pharmacol Rev; 2004 Sep; 56(3):387-437. PubMed ID: 15317910
[TBL] [Abstract][Full Text] [Related]
2. COX-1 and COX-2 in health and disease.
Adelizzi RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs, acetaminophen, cyclooxygenase 2, and fever.
Simmons DL; Wagner D; Westover K
Clin Infect Dis; 2000 Oct; 31 Suppl 5():S211-8. PubMed ID: 11113025
[TBL] [Abstract][Full Text] [Related]
4. New insights into COX-2 biology and inhibition.
Patrignani P; Tacconelli S; Sciulli MG; Capone ML
Brain Res Brain Res Rev; 2005 Apr; 48(2):352-9. PubMed ID: 15850674
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of the human recombinant histidine-tagged prostaglandin endoperoxide H synthases-1 and -2.
Smith T; Leipprandt J; DeWitt D
Arch Biochem Biophys; 2000 Mar; 375(1):195-200. PubMed ID: 10683267
[TBL] [Abstract][Full Text] [Related]
6. [Specific cyclo-oxygenase-2 inhibitors in cardiovascular pathology].
Monsuez JJ
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):632-40. PubMed ID: 15283037
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention.
Qin N; Zhang SP; Reitz TL; Mei JM; Flores CM
J Pharmacol Exp Ther; 2005 Dec; 315(3):1298-305. PubMed ID: 16141368
[TBL] [Abstract][Full Text] [Related]
8. COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Liao Z; Milas L
Expert Rev Anticancer Ther; 2004 Aug; 4(4):543-60. PubMed ID: 15270659
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
Lees P; Landoni MF; Giraudel J; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
[TBL] [Abstract][Full Text] [Related]
10. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition.
Härtel C; von Puttkamer J; Gallner F; Strunk T; Schultz C
Scand J Immunol; 2004 Oct; 60(4):412-20. PubMed ID: 15379866
[TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibition as a tool to treat and prevent colorectal cancer.
Tuynman JB; Peppelenbosch MP; Richel DJ
Crit Rev Oncol Hematol; 2004 Nov; 52(2):81-101. PubMed ID: 15501074
[TBL] [Abstract][Full Text] [Related]
13. The role of cyclooxygenase-2 in the pathogenesis of skin cancer.
Brecher AR
J Drugs Dermatol; 2002 Jul; 1(1):44-7. PubMed ID: 12847753
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in inducible cyclooxygenase (COX-2) inhibition.
de Leval X; Delarge J; Somers F; de Tullio P; Henrotin Y; Pirotte B; Dogné JM
Curr Med Chem; 2000 Oct; 7(10):1041-62. PubMed ID: 10911017
[TBL] [Abstract][Full Text] [Related]
15. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 and its role in ovulation: a 2004 account.
Sirois J; Sayasith K; Brown KA; Stock AE; Bouchard N; Doré M
Hum Reprod Update; 2004; 10(5):373-85. PubMed ID: 15205395
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase and nitric oxide systems in the gut as therapeutic targets for safer anti-inflammatory drugs.
Whittle BJ
Curr Opin Pharmacol; 2004 Dec; 4(6):538-45. PubMed ID: 15525540
[TBL] [Abstract][Full Text] [Related]
18. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
19. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Radi ZA; Khan NK
Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
[TBL] [Abstract][Full Text] [Related]
20. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
